Linus Biotechnology develops a technology platform to improve human health through precision exposome medicine.
Linus Biotechnology has raised $6.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2024.
Linus Biotechnology's investors include GreatPoint Ventures, Bow Capital, Divergent Investments, Sanford Robertson, David Bellet Family Office.
Linus Biotechnology is headquartered in New Rochelle, United States.
Linus Biotechnology develops a technology platform to improve human health through precision exposome medicine.
Linus Biotechnology is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Linus Biotechnology — Funding & Investors." VCBacked, August 12, 2024, https://www.vcbacked.co/company/linus-biotechnology. Accessed September 30, 2026.
VCBacked. (2024). Linus Biotechnology — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/linus-biotechnology
{{cite web |title=Linus Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/linus-biotechnology |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated